Search Results - "Munoz, Irene Guijarro"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Bevacizumab beyond disease progression for advanced non–small cell lung cancer: Does persistence have its rewards? by GuijarroMuñoz, Irene, Roarty, Emily B., Heymach, John V.

    Published in Cancer (01-04-2016)
    “…Persistence pays off when it comes to the vascular endothelial growth factor inhibitor bevacizumab in non–small cell lung cancer patients who have progressed…”
    Get full text
    Journal Article
  2. 2

    Antibody gene therapy: getting closer to clinical application? by Guijarro-Muñoz, Irene, Compte, Marta, Alvarez-Vallina, Luis, Sanz, Laura

    Published in Current gene therapy (01-08-2013)
    “…Monoclonal antibodies are successfully used in the clinic. However, repeated high-dose bolus injections imply high costs. As an alternative to recombinant…”
    Get more information
    Journal Article
  3. 3

    Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes by Guijarro-Muñoz, Irene, Compte, Marta, Álvarez-Cienfuegos, Ana, Álvarez-Vallina, Luis, Sanz, Laura

    Published in The Journal of biological chemistry (24-01-2014)
    “…Pericytes and mesenchymal stem cells (MSCs) are ontogenically related, and in fact, no significant phenotypic differences could be observed by flow cytometry…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    The heterotrimeric laminin coiled-coil domain exerts anti-adhesive effects and induces a pro-invasive phenotype by Santos-Valle, Patricia, Guijarro-Muñoz, Irene, Cuesta, Angel M, Alonso-Camino, Vanesa, Villate, Maider, Alvarez-Cienfuegos, Ana, Blanco, Francisco J, Sanz, Laura, Alvarez-Vallina, Luis

    Published in PloS one (19-06-2012)
    “…Laminins are large heterotrimeric cross-shaped extracellular matrix glycoproteins with terminal globular domains and a coiled-coil region through which the…”
    Get full text
    Journal Article
  9. 9
  10. 10